{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:56:29Z","timestamp":1777341389555,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T00:00:00Z","timestamp":1362441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00125-013-2861-9","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T05:52:05Z","timestamp":1362462725000},"page":"1118-1128","source":"Crossref","is-referenced-by-count":18,"title":["Knockdown of PRAS40 inhibits insulin action via proteasome-mediated degradation of IRS1 in primary human skeletal muscle cells"],"prefix":"10.1007","volume":"56","author":[{"given":"C.","family":"Wiza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Herzfeld de Wiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. B. M.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Al-Hasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. M.","family":"Ouwens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"2861_CR1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ijo.2010.208","volume":"35","author":"C Catania","year":"2011","unstructured":"Catania C, Binder E, Cota D (2011) mTORC1 signaling in energy balance and metabolic disease. Int J Obes 35:751\u2013761","journal-title":"Int J Obes"},{"key":"2861_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21\u201335","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2861_CR3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tem.2010.12.003","volume":"22","author":"JJ Howell","year":"2011","unstructured":"Howell JJ, Manning BD (2011) mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metabol 22:94\u2013102","journal-title":"Trends Endocrinol Metabol"},{"key":"2861_CR4","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1210\/en.2004-0777","volume":"146","author":"F Tremblay","year":"2005","unstructured":"Tremblay F, Gagnon A, Veilleux A, Sorisky A, Marette A (2005) Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology 146:1328\u20131337","journal-title":"Endocrinology"},{"key":"2861_CR5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2004-0921","volume":"146","author":"L Khamzina","year":"2005","unstructured":"Khamzina L, Veilleux A, Bergeron S, Marette A (2005) Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146:1473\u20131481","journal-title":"Endocrinology"},{"key":"2861_CR6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","volume":"431","author":"SH Um","year":"2004","unstructured":"Um SH, Frigerio F, Watanabe M et al (2004) Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200\u2013205","journal-title":"Nature"},{"key":"2861_CR7","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s00125-006-0439-5","volume":"49","author":"E Korsheninnikova","year":"2006","unstructured":"Korsheninnikova E, van der Zon GC, Voshol PJ et al (2006) Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. Diabetologia 49:3049\u20133057","journal-title":"Diabetologia"},{"key":"2861_CR8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00125-004-1662-6","volume":"48","author":"M Ueno","year":"2005","unstructured":"Ueno M, Carvalheira JB, Tambascia RC et al (2005) Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1\/2 serine phosphorylation and the mTOR\/p70 S6K pathway. Diabetologia 48:506\u2013518","journal-title":"Diabetologia"},{"key":"2861_CR9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.1199498","volume":"332","author":"PP Hsu","year":"2011","unstructured":"Hsu PP, Kang SA, Rameseder J et al (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332:1317\u20131322","journal-title":"Science"},{"key":"2861_CR10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1126\/science.1208071","volume":"332","author":"SS Yea","year":"2011","unstructured":"Yea SS, Fruman DA (2011) Cell signaling. New mTOR targets Grb attention. Science 332:1270\u20131271","journal-title":"Science"},{"key":"2861_CR11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Y Yu","year":"2011","unstructured":"Yu Y, Yoon SO, Poulogiannis G et al (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332:1322\u20131326","journal-title":"Science"},{"key":"2861_CR12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852\u2013871","journal-title":"Cell"},{"key":"2861_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00125-007-0862-2","volume":"51","author":"IM Jazet","year":"2008","unstructured":"Jazet IM, Schaart G, Gastaldelli A et al (2008) Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia 51:309\u2013319","journal-title":"Diabetologia"},{"key":"2861_CR14","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2337\/db05-1390","volume":"55","author":"EB Nascimento","year":"2006","unstructured":"Nascimento EB, Fodor M, van der Zon GC et al (2006) Insulin-mediated phosphorylation of the proline-rich Akt substrate PRAS40 is impaired in insulin target tissues of high-fat diet-fed rats. Diabetes 55:3221\u20133228","journal-title":"Diabetes"},{"key":"2861_CR15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cellsig.2010.02.002","volume":"22","author":"EB Nascimento","year":"2010","unstructured":"Nascimento EB, Snel M, Guigas B et al (2010) Phosphorylation of PRAS40 on Thr246 by PKB\/AKT facilitates efficient phosphorylation of Ser183 by mTORC1. Cell Signal 22:961\u2013967","journal-title":"Cell Signal"},{"key":"2861_CR16","doi-asserted-by":"crossref","first-page":"E1453","DOI":"10.1152\/ajpendo.00660.2011","volume":"302","author":"C Wiza","year":"2012","unstructured":"Wiza C, Nascimento EB, Ouwens DM (2012) Role of PRAS40 in Akt and mTOR signaling in health and disease. Am J Physiol Endocrinol Metab 302:E1453\u2013E1460","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2861_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cellsig.2011.08.010","volume":"24","author":"H Wang","year":"2012","unstructured":"Wang H, Zhang Q, Wen Q et al (2012) Proline-rich Akt substrate of 40\u00a0kDa (PRAS40): a novel downstream target of PI3K\/Akt signaling pathway. Cell Signal 24:17\u201324","journal-title":"Cell Signal"},{"key":"2861_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jcp.22186","volume":"225","author":"N Dey","year":"2010","unstructured":"Dey N, Ghosh-Choudhury N, Das F et al (2010) PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy. J Cell Physiol 225:27\u201341","journal-title":"J Cell Physiol"},{"key":"2861_CR19","doi-asserted-by":"crossref","first-page":"20329","DOI":"10.1074\/jbc.M702636200","volume":"282","author":"N Oshiro","year":"2007","unstructured":"Oshiro N, Takahashi R, Yoshino K et al (2007) The proline-rich Akt substrate of 40\u00a0kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J Biol Chem 282:20329\u201320339","journal-title":"J Biol Chem"},{"key":"2861_CR20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","volume":"25","author":"Y Sancak","year":"2007","unstructured":"Sancak Y, Thoreen CC, Peterson TR et al (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25:903\u2013915","journal-title":"Mol Cell"},{"key":"2861_CR21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncb1547","volume":"9","author":"E Vander Haar","year":"2007","unstructured":"Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH (2007) Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40. Nat Cell Biol 9:316\u2013323","journal-title":"Nat Cell Biol"},{"key":"2861_CR22","doi-asserted-by":"crossref","first-page":"24514","DOI":"10.1074\/jbc.M704406200","volume":"282","author":"BD Fonseca","year":"2007","unstructured":"Fonseca BD, Smith EM, Lee VH, MacKintosh C, Proud CG (2007) PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J Biol Chem 282:24514\u201324524","journal-title":"J Biol Chem"},{"key":"2861_CR23","doi-asserted-by":"crossref","first-page":"20036","DOI":"10.1074\/jbc.M702376200","volume":"282","author":"L Wang","year":"2007","unstructured":"Wang L, Harris TE, Roth RA, Lawrence JC Jr (2007) PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 282:20036\u201320044","journal-title":"J Biol Chem"},{"key":"2861_CR24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.devcel.2011.10.029","volume":"22","author":"C Pallares-Cartes","year":"2012","unstructured":"Pallares-Cartes C, Cakan-Akdogan G, Teleman AA (2012) Tissue-specific coupling between insulin\/IGF and TORC1 signaling via PRAS40 in Drosophila. Dev Cell 22:172\u2013182","journal-title":"Dev Cell"},{"key":"2861_CR25","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1210\/en.2005-0969","volume":"147","author":"H Sell","year":"2006","unstructured":"Sell H, Dietze-Schroeder D, Kaiser U, Eckel J (2006) Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 147:2458\u20132467","journal-title":"Endocrinology"},{"key":"2861_CR26","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2337\/db09-0277","volume":"58","author":"H Sell","year":"2009","unstructured":"Sell H, Laurencikiene J, Taube A et al (2009) Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58:2731\u20132740","journal-title":"Diabetes"},{"key":"2861_CR27","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/diabetes.51.8.2369","volume":"51","author":"D Dietze","year":"2002","unstructured":"Dietze D, Koenen M, Rohrig K, Horikoshi H, Hauner H, Eckel J (2002) Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51:2369\u20132376","journal-title":"Diabetes"},{"key":"2861_CR28","doi-asserted-by":"crossref","first-page":"33116","DOI":"10.1016\/S0021-9258(20)30104-6","volume":"269","author":"DM Ouwens","year":"1994","unstructured":"Ouwens DM, van der Zon GC, Pronk GJ et al (1994) A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation. J Biol Chem 269:33116\u201333122","journal-title":"J Biol Chem"},{"key":"2861_CR29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/BJ20101024","volume":"431","author":"LR Pearce","year":"2010","unstructured":"Pearce LR, Alton GR, Richter DT et al (2010) Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Biochem J 431:245\u2013255","journal-title":"Biochem J"},{"key":"2861_CR30","doi-asserted-by":"crossref","first-page":"E1283","DOI":"10.1152\/ajpendo.00676.2009","volume":"298","author":"CH Lang","year":"2010","unstructured":"Lang CH, Frost RA, Bronson SK, Lynch CJ, Vary TC (2010) Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine. Am J Physiol Endocrinol Metab 298:E1283\u2013E1294","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2861_CR31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00726-010-0765-2","volume":"41","author":"N Chotechuang","year":"2011","unstructured":"Chotechuang N, Azzout-Marniche D, Bos C, Chaumontet C, Gaudichon C, Tome D (2011) Down-regulation of the ubiquitin-proteasome proteolysis system by amino acids and insulin involves the adenosine monophosphate-activated protein kinase and mammalian target of rapamycin pathways in rat hepatocytes. Amino Acids 41:457\u2013468","journal-title":"Amino Acids"},{"key":"2861_CR32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2119\/molmed.2009.00168","volume":"16","author":"AA Kazi","year":"2010","unstructured":"Kazi AA, Lang CH (2010) PRAS40 regulates protein synthesis and cell cycle in C2C12 myoblasts. Mol Med 16:359\u2013371","journal-title":"Mol Med"},{"key":"2861_CR33","doi-asserted-by":"crossref","first-page":"38043","DOI":"10.1074\/jbc.M111.245449","volume":"286","author":"J Rapley","year":"2011","unstructured":"Rapley J, Oshiro N, Ortiz-Vega S, Avruch J (2011) The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling. J Biol Chem 286:38043\u201338053","journal-title":"J Biol Chem"},{"key":"2861_CR34","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/jcb.22496","volume":"109","author":"LQ Hong-Brown","year":"2010","unstructured":"Hong-Brown LQ, Brown CR, Kazi AA, Huber DS, Pruznak AM, Lang CH (2010) Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction. J Cell Biochem 109:1172\u20131184","journal-title":"J Cell Biochem"},{"key":"2861_CR35","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1006\/bbrc.1993.1143","volume":"190","author":"KM Rice","year":"1993","unstructured":"Rice KM, Turnbow MA, Garner CW (1993) Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 190:961\u2013967","journal-title":"Biochem Biophys Res Commun"},{"key":"2861_CR36","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2337\/diabetes.48.7.1359","volume":"48","author":"XJ Sun","year":"1999","unstructured":"Sun XJ, Goldberg JL, Qiao LY, Mitchell JJ (1999) Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48:1359\u20131364","journal-title":"Diabetes"},{"key":"2861_CR37","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","volume":"277","author":"L Rui","year":"2002","unstructured":"Rui L, Yuan M, Frantz D, Shoelson S, White MF (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277:42394\u201342398","journal-title":"J Biol Chem"},{"key":"2861_CR38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.devcel.2011.09.011","volume":"21","author":"J Shi","year":"2011","unstructured":"Shi J, Luo L, Eash J, Ibebunjo C, Glass DJ (2011) The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling. Dev Cell 21:835\u2013847","journal-title":"Dev Cell"},{"key":"2861_CR39","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1128\/MCB.01347-08","volume":"29","author":"R Nakao","year":"2009","unstructured":"Nakao R, Hirasaka K, Goto J et al (2009) Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading. Mol Cell Biol 29:4798\u20134811","journal-title":"Mol Cell Biol"},{"key":"2861_CR40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.molcel.2008.03.009","volume":"30","author":"X Xu","year":"2008","unstructured":"Xu X, Sarikas A, Dias-Santagata DC et al (2008) The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell 30:403\u2013414","journal-title":"Mol Cell"},{"key":"2861_CR41","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.molcel.2012.09.029","volume":"48","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Destefano MA, Oh WJ et al (2012) mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. Mol Cell 48:875\u2013887","journal-title":"Mol Cell"},{"key":"2861_CR42","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/en.2006-0251","volume":"147","author":"X Wang","year":"2006","unstructured":"Wang X, Hu Z, Hu J, Du J, Mitch WE (2006) Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147:4160\u20134168","journal-title":"Endocrinology"},{"key":"2861_CR43","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/S0021-9258(18)53873-4","volume":"268","author":"DC Fingar","year":"1993","unstructured":"Fingar DC, Hausdorff SF, Blenis J, Birnbaum MJ (1993) Dissociation of pp 70 ribosomal protein S6 kinase from insulin-stimulated glucose transport in 3T3\u2013L1 adipocytes. J Biol Chem 268:3005\u20133008","journal-title":"J Biol Chem"},{"key":"2861_CR44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","volume":"8","author":"CF Bentzinger","year":"2008","unstructured":"Bentzinger CF, Romanino K, Cloetta D et al (2008) Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 8:411\u2013424","journal-title":"Cell Metab"},{"key":"2861_CR45","doi-asserted-by":"crossref","first-page":"26754","DOI":"10.1074\/jbc.M311802200","volume":"279","author":"J Murdaca","year":"2004","unstructured":"Murdaca J, Treins C, Monthouel-Kartmann MN et al (2004) Grb10 prevents Nedd4-mediated vascular endothelial growth factor receptor-2 degradation. J Biol Chem 279:26754\u201326761","journal-title":"J Biol Chem"},{"key":"2861_CR46","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1128\/MCB.02087-06","volume":"27","author":"FM Smith","year":"2007","unstructured":"Smith FM, Holt LJ, Garfield AS et al (2007) Mice with a disruption of the imprinted Grb10 gene exhibit altered body composition, glucose homeostasis, and insulin signaling during postnatal life. Mol Cell Biol 27:5871\u20135886","journal-title":"Mol Cell Biol"},{"key":"2861_CR47","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1210\/me.2008-0386","volume":"23","author":"LJ Holt","year":"2009","unstructured":"Holt LJ, Lyons RJ, Ryan AS et al (2009) Dual ablation of Grb10 and Grb14 in mice reveals their combined role in regulation of insulin signaling and glucose homeostasis. Mol Endocrinol 23:1406\u20131414","journal-title":"Mol Endocrinol"},{"key":"2861_CR48","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00125-003-1223-4","volume":"46","author":"P Gual","year":"2003","unstructured":"Gual P, Gremeaux T, Gonzalez T, Le Marchand-Brustel Y, Tanti JF (2003) MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632. Diabetologia 46:1532\u20131542","journal-title":"Diabetologia"},{"key":"2861_CR49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/me.16.3.552","volume":"16","author":"X Xiang","year":"2002","unstructured":"Xiang X, Yuan M, Song Y, Ruderman N, Wen R, Luo Z (2002) 14-3-3 facilitates insulin-stimulated intracellular trafficking of insulin receptor substrate 1. Mol Endocrinol 16:552\u2013562","journal-title":"Mol Endocrinol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2861-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-013-2861-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2861-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T21:21:00Z","timestamp":1715030460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-013-2861-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2861"],"URL":"https:\/\/doi.org\/10.1007\/s00125-013-2861-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,5]]}}}